On today’s STOP TRADING segment on CNBC, Jim Cramer covered a few issues.
He noted Pfizer (PFE) again, saying it was another Bristol-Myers (BMY). He said it is a $25.00 bond now, that has almost no upside. Regarding the safety board, he said them not even knowing of a possibility of issues.
Going hunting, Cramer said Cabellas (CAB) is one that is winning from hunting trends again. He said the analysts also refuse to upgrade it and they might be wrong.
Cramer thinks Archer-Daniels (ADM) is a winner trading cheap.
Jon C. Ogg
December 4, 2006
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.